期刊文献+

加味己椒苈黄汤治疗COPD肺动脉高压的临床研究 被引量:15

Clinical Study on “Jijiao Lihuang Decoction” in Treating Pulmonary Hypertension of Chronic Obstructive Pulmonary Disease
在线阅读 下载PDF
导出
摘要 研究加味己椒苈黄汤对慢性阻塞性肺疾病肺动脉高压患者肺动脉平均压的影响。60例慢性阻塞性肺疾病(COPD)肾阳虚同时伴有肺动脉平均压升高患者,随机分为加味己椒苈黄汤治疗组和硝苯地平对照组(各30例),治疗14天,观察临床总有效率、临床症状积分、肺动脉平均压、肺功能等指标及不良反应。结果:治疗组总有效率为86. 67%,明显高于对照组总有效率40% (P<0 01);两组均能明显降低COPD伴肺动脉高压患者的肺动脉平均压(P<0. 01),且治疗组优于对照组(P<0. 05);但是对肺功能的改善两组都不明显(P>0. 05)。结论:中药加味己椒苈黄汤治疗慢性阻塞性肺疾病肺动脉高压具有良好的疗效,其作用优于硝苯地平。 To study the effects of “Jijiao Lihuang Decoction” on the average pulmonary pressure of chronic obstructive pulmonary disease(COPD) with pulmonary hypertension of kidney yang deficiency, 60 subjects were randomized into two groups: treatment group in which 30 cases were treated with this Decoction and control group in which another 30 cases were treated with nifedipine, with a course of 14 days. The total effective rate, clinical symptom score, average pulmonary pressure and lung function were observed. Results: The total effective rate was 86.67% in treatment group, higher than 40.00% in control group ( P <0.01); in both groups, the average pulmonary pressure dropped ( P <0.01), with more obvious drop in treatment group than in control group ( P <0.05), but the lung functions improved little( P >0.05). Conclusion: This Decoction has better effect on pulmonary hypertension than nifedipine.
出处 《上海中医药杂志》 北大核心 2005年第6期24-25,共2页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市卫生局基金资助项目(00-9-05)。
关键词 加味己椒苈黄汤 肾阳虚 慢性阻塞性肺疾病 肺动脉高压 肺动脉平均压 Jijiao Lihuang Decoction” kidney yang deficiency chronic obstructive pulmonary disease pulmonary hypertension average pulmonary pressure
  • 相关文献

参考文献6

  • 1李景周.当归对肺心病肺动脉压的作用[J].中华结核和呼吸杂志,1992,15(3):169-169.
  • 2王辰,张洪玉.肺动脉高压诊断标准和慢性肺心病定义[J].国外医学(呼吸系统分册),1994,14(2):78-80. 被引量:16
  • 3慢性阻塞性肺疾病(COPD)诊治规范(草案)[J].中华结核和呼吸杂志,1997,20(4):199-203. 被引量:1381
  • 4Viegi G, Scognamiglio A, Baldacci S, et al. Epidemiology of chronic obstructive pulmonary disease ( COPD ) [ J ]. Respiration, 2001,68(1) :4-19.
  • 5Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHL BI/WHO Global Initiative for Chronic Obstructive Lung Disease ( GOLD ) Workshop summary [ J ]. Am J Respir Crit Care Med,2001,163 (5): 1256-1276.
  • 6Xie QM,Tag HF,Chen JQ,et al. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases[ J]. Acta Pharmacol Sin,2002,23(12) :1107-1113.

共引文献1402

同被引文献282

引证文献15

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部